查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1819882

寡核苷酸合成市场报告（按产品、应用（PCR 引子、PCR 检测和组合、定序、DNA 微阵列、萤光原位杂交、反义寡核苷酸等）、最终用途和地区划分，2025 年至 2033 年）

Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球寡核苷酸合成市场规模达33亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到86亿美元，2025-2033年期间的复合年增长率（CAGR）为10.55%。遗传性疾病在人群中的日益流行、新型治疗策略的不断发展以及小干扰RNA (siRNA)和反义寡核苷酸疗法的广泛应用，是推动市场发展的主要因素。

寡核苷酸合成是指依预定序列建构短DNA或RNA分子（称为寡核苷酸）的过程。这些分子的长度范围从几个碱基到大约200个核苷酸不等。该过程在受控的实验室环境中以化学方式完成，通常使用固相亚磷酰胺化学。在该方法中，核苷酸被依次添加到不断增长的链中，每次添加都涉及一系列化学反应。这项技术使科学家能够产生客製化的寡核苷酸，用于各种应用，包括基因合成、聚合酶炼式反应 (PCR)、基因编辑工具（例如 CRISPR-Cas9）以及分子诊断测试。寡核苷酸合成的进展大大加速了基因组学和分子生物学的研究，为医学和生物学研究的许多突破奠定了基础。

群体中遗传疾病的发生率不断上升，是全球市场的主要驱动力。这促使人们开发新的治疗策略，而寡核苷酸疗法在其中扮演重要角色。例如，使用小干扰RNA (siRNA) 和反义寡核苷酸的疗法正在被研究并用于治疗杜氏肌肉营养不良症和脊髓性肌肉萎缩症等遗传疾病。因此，遗传疾病的日益普及推动了全球范围内的需求。同时，生物资讯学和资料科学的发展对寡核苷酸合成产业产生了直接影响。分析大型基因组资料集的能力不断提升也对市场产生了正面的影响。因此，运算能力的提升正在推动对新型寡核苷酸合成的需求成长。此外，寡核苷酸，特别是反义寡核苷酸，已被证明是表观遗传学研究和治疗的有效工具，有助于调节基因表达，这创造了积极的市场前景。

寡核苷酸合成市场趋势/驱动因素：

医疗保健和製药行业需求不断增长

全球对个人化医疗和疗法的需求正在迅速增长，这导致寡核苷酸合成市场空前扩张。这些合成序列是开发针对各种遗传疾病（包括癌症）的标靶疗法的重要组成部分。同时，反义寡核苷酸、适体、siRNA 和免疫刺激性寡核苷酸等治疗性寡核苷酸的进步，透过特异性抑製或改变基因表达，正在彻底改变疾病治疗。此外，客製化寡核苷酸的合成对于疫苗的生产至关重要，包括基于 mRNA 的 COVID-19 疫苗，这些疫苗已被证明有效并已被广泛使用。随着製药公司和研究人员不断探索寡核苷酸在疾病治疗和预防方面的新应用，寡核苷酸合成的需求也有望上升。

技术进步与创新

寡核苷酸合成技术的稳定发展和完善正在推动市场成长。此外，包括高通量和自动化合成系统在内的合成製程创新，提高了寡核苷酸生产的效率、准确性和可扩展性。此外，生物资讯学和合成生物学的发展，包括DNA定序和基因编辑（例如CRISPR-Cas9），在很大程度上依赖精确合成寡核苷酸的能力。这些进步使得创建具有更高复杂性和多样性的客製化序列成为可能，并促进了合成生物学的快速原型测试，从而促进了更高效的研发。这些持续的技术进步和发展也为市场做出了贡献。

不断增长的合作与伙伴关係

製药公司、生技公司和研究机构之间的合作与伙伴关係已成为推动遗传疾病寡核苷酸疗法开发和商业化的重要驱动力。这些合作汇集了多元化的专业知识、资源和资金，创造了协同增效的环境，加速了科学发现转化为实用有效的治疗方法。製药公司凭藉其在药物开发、临床试验和监管流程方面的经验，为合作贡献了至关重要的专业知识。他们拥有必要的基础设施、知识和资源，能够应对复杂的药物开发环境，并确保寡核苷酸疗法符合安全性和有效性的监管标准。他们的参与有助于利用现有的网路、製造能力和分销管道，简化商业化路径。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球寡核苷酸合成市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 合成寡核苷酸产品
  • 试剂
  • 装置
  • 服务

第七章：市场区隔：依应用

  • PCR引子
  • PCR检测与检测组
  • 定序
  • DNA微阵列
  • 萤光原位杂交（FISH）
  • 反义寡核苷酸
  • 其他的

第 8 章：市场区隔：最终用途别

  • 製药和生物技术公司
  • 医院和诊断实验室
  • 学术研究机构

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Biolegio BV
    • Bio-Synthesis Inc
    • Eurofins Genomics
    • GenScript
    • Horizon Discovery Ltd
    • Integrated DNA Technologies Inc (Danaher Corporation)
    • Kaneka Eurogentec SA (Kaneka Corporation)
    • LGC Limited
    • Nitto Denko Avecia Inc (Nitto Denko Corporation)
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3812

The global oligonucleotide synthesis market size reached USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.6 Billion by 2033, exhibiting a growth rate (CAGR) of 10.55% during 2025-2033. The growing prevalence of genetic diseases among the masses, the development of novel therapeutic strategies, and the widespread adoption of therapies using small interfering RNAs (siRNAs), and antisense oligonucleotides are some of the major factors propelling the market.

Oligonucleotide synthesis refers to the process of constructing short DNA or RNA molecules, called oligonucleotides, in a predetermined sequence. These can range from just a few bases to around 200 nucleotides in length. The process is accomplished chemically in a controlled laboratory environment, typically using solid phase phosphoramidite chemistry. In this method, nucleotides are sequentially added to a growing chain, each addition involving a series of chemical reactions. This technology enables scientists to generate custom-made oligonucleotides for various applications including gene synthesis, polymerase chain reaction (PCR), gene editing tools, such as CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have dramatically accelerated research in genomics and molecular biology, underpinning many breakthroughs in medical and biological research.

The rising prevalence of genetic diseases among the masses majorly drives the global market. This necessitates the development of novel therapeutic strategies, where oligonucleotide-based therapies play a significant role. For instance, therapies using small interfering RNAs (siRNAs) and antisense oligonucleotides are being investigated and utilized in the treatment of genetic disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy. As such, the growing prevalence of genetic diseases drives the demand on the global level. Along with this, the growth of bioinformatics and data science has a direct impact on the oligonucleotide synthesis industry. The escalating capacity to analyze large genomic datasets is also positively influencing the market. Therefore, the rising computational capability is driving an increased demand for the synthesis of novel oligonucleotides. Furthermore, oligonucleotides particularly antisense oligonucleotides, have been shown to be effective tools in epigenetic research and therapy, helping to modulate gene expression, which is creating a positive market outlook.

Oligonucleotide Synthesis Market Trends/Drivers:

Rising Demand in the Healthcare and Pharmaceutical Industries

The global demand for personalized medicine and therapeutics is rapidly increasing, leading to an unprecedented expansion in the oligonucleotide synthesis market. These synthesized sequences are integral components in developing targeted therapies for various genetic disorders and diseases, including cancer. Along with this, the advancement of therapeutic oligonucleotides, such as antisense oligonucleotides, aptamers, siRNAs, and immunostimulatory oligonucleotides, is revolutionizing disease treatment by specifically inhibiting or altering gene expression. Furthermore, the synthesis of custom oligonucleotides is fundamental to the production of vaccines, including mRNA-based COVID-19 vaccines, which have proven effective and are now widely used. As pharmaceutical companies and researchers continue to discover novel applications for oligonucleotides in the treatment and prevention of diseases, the demand for oligonucleotide synthesis is poised to rise.

Technological Advancements and Innovation

The steady development and refinement of oligonucleotide synthesis technologies are driving market growth. In addition, innovations in the synthesis process, including high-throughput and automated synthesis systems, have increased the efficiency, accuracy, and scalability of oligonucleotide production. Moreover, developments in bioinformatics and synthetic biology, including DNA sequencing and gene editing (e.g., CRISPR-Cas9), heavily rely on the ability to synthesize oligonucleotides accurately. These advancements allow for the creation of custom sequences with greater complexity and diversity and facilitate rapid prototype testing in synthetic biology, thereby fostering more efficient research and development. These continuous technological advancements and developments are also contributing to the market.

Growing Collaborations and Partnerships

Collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become essential drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborations bring together diverse expertise, resources, and funding, creating a synergistic environment that accelerates the translation of scientific discoveries into practical and effective treatments. Pharmaceutical companies, with their experience in drug development, clinical trials, and regulatory processes, contribute vital expertise to the collaboration. They have the infrastructure, knowledge, and resources necessary to navigate the complex landscape of drug development and ensure that oligonucleotide therapies meet regulatory standards for safety and efficacy. Their involvement helps streamline the path to commercialization by leveraging existing networks, manufacturing capabilities, and distribution channels.

Oligonucleotide Synthesis Industry Segmentation:

Breakup by Product:

  • Synthesized Oligonucleotide Products
  • Reagents
  • Equipment
  • Services

Synthesized oligonucleotide products dominate the market

The market for synthesized oligonucleotide products in the oligonucleotide synthesis industry is being driven by the ever-increasing demand from pharmaceutical and biotechnological companies for drug discovery and development, especially for personalized medicine and targeted therapeutics. Along with this, the rise in genomics and molecular research, fueled by significant advancements in technologies such as Next Generation Sequencing (NGS) and CRISPR gene-editing, is enhancing the requirement for synthesized oligonucleotides. Additionally, the growth in diagnostic applications of oligonucleotides, such as in PCR and microarray assays for genetic and infectious diseases, is propelling the market forward. The expanding field of epigenetics also represents a key driver, with oligonucleotides playing a crucial role in gene expression studies. Moreover, the increasing prevalence of genetic disorders and the resultant demand for novel therapeutic strategies involving oligonucleotides further accelerates the market growth for synthesized oligonucleotide products.

Breakup by Application:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In-Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

PCR primers dominate the market

The demand for PCR primers in the oligonucleotide synthesis industry is driven by the ongoing global health crisis necessitating extensive viral testing, in which PCR is a primary method. Furthermore, the increasing application of PCR in medical diagnostics, forensics, and research to detect genetic mutations and infectious diseases fuels the demand for primers. In the field of genomics and molecular biology, PCR is considered a crucial tool for DNA sequencing, cloning, and genetic manipulation, and this broad utilization further drives the need for PCR primer synthesis. Apart from this, technological advancements in PCR techniques, such as real-time PCR and digital PCR, are also playing a role in boosting demand. Moreoevr, the growing funding for research in healthcare and life sciences has resulted in expanded use of PCR, thus driving the demand for PCR primers in the overall industry.

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • Hospital and Diagnostic Laboratories
  • Academic Research Institutes

Academic research institutes dominate the market

The demand for oligonucleotide synthesis in academic research institutes is driven by a rise in genomics and molecular biology research, particularly studies related to gene expression, genetic disorders, and the development of novel therapeutic strategies. Additionally, advancements in technologies such as Next-Generation Sequencing (NGS) and CRISPR gene-editing, which rely on synthesized oligonucleotides, are stimulating demand. In addition, the rising trend of interdisciplinary studies involving bioinformatics and data science, which necessitate the use of oligonucleotides for data validation, further drives the need. Governmental and institutional funding for genomics and biotechnology research is another major driver, enabling academic institutes to invest in oligonucleotide synthesis for various projects. Academic research institutes, with their focus on fundamental research and discovery, often possess cutting-edge knowledge and innovative ideas. By partnering with industry, they can translate their scientific findings into practical applications and commercial products.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest oligonucleotide synthesis market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North American market for oligonucleotide synthesis is propelled by a robust pharmaceutical and biotech industry, with a strong focus on drug discovery and development. The region's emphasis on personalized medicine and targeted therapies further propels this need. Additionally, North America's sophisticated healthcare system with advanced diagnostic capabilities increases the demand for oligonucleotides in diagnostic assays. The region also hosts numerous top-tier academic and research institutes conducting extensive genomics and molecular biology research, which necessitates oligonucleotide synthesis. Moreover, strong governmental and private sector investment in healthcare and life sciences research, particularly in genomics and personalized medicine, fuels the growth of industry in North America. Moreover, the advancements in delivery systems and formulations for oligonucleotide-based therapeutics in North America demonstrate the region's commitment to pushing the boundaries of innovation in this field. These developments not only contribute to the growth of the market but also have the potential to revolutionize the treatment of various diseases, including genetic disorders, cancers, and rare diseases.

Competitive Landscape:

The global oligonucleotide synthesis market is experiencing significant growth due to the escalating investments in the development of new production facilities, upgrading existing ones, and implementing more efficient production processes. Therefore, Companies are heavily investing in research and development to innovate their offerings, including developing new synthesis techniques, improving the scale and accuracy of synthesis, and creating new types of oligonucleotide products to support various applications in diagnostics, therapeutics, and research. Along with this, companies are entering into strategic collaborations, partnerships, and acquisitions to co-develop oligonucleotide-based drugs, share technology and expertise, or expand into new markets. In addition, the introduction of therapeutics, such as antisense oligonucleotides, siRNAs, and miRNAs, offer new avenues for treating a wide range of diseases, including genetic disorders and cancers is positively influencing the market. Furthermore, key players are offering services for the custom synthesis of oligonucleotides. This allows researchers and developers to order specific oligonucleotide sequences tailored to their needs, which is particularly important in fields like genomics, molecular biology, and personalized medicine.

The report has provided a comprehensive analysis of the competitive landscape in the global oligonucleotide synthesis market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Biolegio B.V.
  • Bio-Synthesis Inc
  • Eurofins Genomics
  • GenScript
  • Horizon Discovery Ltd
  • Integrated DNA Technologies Inc (Danaher Corporation)
  • Kaneka Eurogentec S.A. (Kaneka Corporation)
  • LGC Limited
  • Nitto Denko Avecia Inc (Nitto Denko Corporation)
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global oligonucleotide synthesis market in 2024?
  • 2.What is the expected growth rate of the global oligonucleotide synthesis market during 2025-2033?
  • 3.What are the key factors driving the global oligonucleotide synthesis market?
  • 4.What has been the impact of COVID-19 on the global oligonucleotide synthesis market?
  • 5.What is the breakup of the global oligonucleotide synthesis market based on the product?
  • 6.What is the breakup of the global oligonucleotide synthesis market based on the application?
  • 7.What is the breakup of the global oligonucleotide synthesis market based on end use?
  • 8.What are the key regions in the global oligonucleotide synthesis market?
  • 9.Who are the key players/companies in the global oligonucleotide synthesis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oligonucleotide Synthesis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Synthesized Oligonucleotide Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Equipment
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 PCR Primers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Assays and Panels
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Microarrays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fluorescence In-Situ Hybridization (FISH)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Antisense Oligonucleotides
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital and Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biolegio B.V.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Synthesis Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Genomics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 GenScript
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Horizon Discovery Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integrated DNA Technologies Inc (Danaher Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 LGC Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oligonucleotide Synthesis Market: Major Drivers and Challenges
  • Figure 2: Global: Oligonucleotide Synthesis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oligonucleotide Synthesis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Oligonucleotide Synthesis Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Oligonucleotide Synthesis Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Oligonucleotide Synthesis Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Oligonucleotide Synthesis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oligonucleotide Synthesis (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oligonucleotide Synthesis (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oligonucleotide Synthesis (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oligonucleotide Synthesis (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oligonucleotide Synthesis (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oligonucleotide Synthesis (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oligonucleotide Synthesis (PCR Primers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oligonucleotide Synthesis (PCR Primers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oligonucleotide Synthesis (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oligonucleotide Synthesis (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oligonucleotide Synthesis (DNA Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oligonucleotide Synthesis (DNA Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Oligonucleotide Synthesis (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Oligonucleotide Synthesis (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Oligonucleotide Synthesis Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Oligonucleotide Synthesis Industry: SWOT Analysis
  • Figure 86: Global: Oligonucleotide Synthesis Industry: Value Chain Analysis
  • Figure 87: Global: Oligonucleotide Synthesis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oligonucleotide Synthesis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Oligonucleotide Synthesis Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oligonucleotide Synthesis Market: Competitive Structure
  • Table 7: Global: Oligonucleotide Synthesis Market: Key Players